NCT01452815 Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis Status COMPLETED Phase PHASE2
NCT01394055 Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis Status COMPLETED Phase PHASE1
NCT01329211 Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers Status TERMINATED Phase N/A
NCT01326117 Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis Status WITHDRAWN Phase PHASE4
NCT01323582 Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis Status TERMINATED Phase PHASE2
NCT01316484 Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms Status COMPLETED Phase N/A
NCT01294566 FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers Status COMPLETED Phase PHASE1
NCT01286090 An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus Status TERMINATED Phase PHASE4
NCT01281540 An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options Status TERMINATED Phase PHASE4
NCT01267071 A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01262898 Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis Status COMPLETED Phase PHASE2
NCT01206582 A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) Status COMPLETED Phase PHASE2
NCT01173484 Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification Status TERMINATED Phase N/A
NCT01149369 Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial Status COMPLETED Phase PHASE2
NCT01135186 Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis. Status COMPLETED Phase NA
NCT01117376 Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients Status TERMINATED Phase PHASE2
NCT01074710 Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers Status COMPLETED Phase PHASE1